Most adults with acromegaly reduced IGF-1 levels and improved acromegaly symptoms with once-monthly subcutaneous octreotide ...

Dan Ives, the global head of technology research at Wedbush Securities, believes that one stock market segment will continue to surprise investors with its upside in the next five years.

Growth-hormone-releasing hormone (GHRH) and its receptors are expressed in a wide variety of normal and malignant tissues. This article describes various GHRH antagonists, their mechanisms of ...